Arterial calcification is a common cardiovascular disease that initiates from a process of osteoblastic differentiation of vascular smooth muscle cells (VSMCs). Accumulating evidence has demonstrated that microRNAs play an important role in regulating arterial calcification. miR-204 was significantly downregulated in calcified human renal arteries from patients with uremia; calcified arteries of mice, due to 5/6 nephrectomy with a high-phosphate diet (5/6 NTP); and in VSMCs induced by high phosphate concentration. The overexpression of miR-204 alleviated the osteoblastic differentiation of VSMCs. Bisulphite sequencing PCR revealed that CpG sites upstream of miR-204 DNA were hypermethylated in calcified VSMCs; in calcified arteries of mice, due to 5/6 NTP; and in calcified renal artery tissues from patients with uremia. Moreover, increased DNMT3a resulted in the hypermethylation of miR-204 in high phosphate concentration-induced VSMCs, whereas 5-aza-2 0 -deoxycytidine could restore the expression of miR-204 in high phosphate concentrationinduced VSMCs. Moreover, we found that DNMT3a was the target of miR-204, and the methylation ratio of miR-204 was decreased significantly, meaning that the expression of miR-204 was restored when DNMT3a was knocked down by using DNMT3a small interfering RNA, resulting in abrogation of the effect of high phosphate concentration on VSMC calcification. The progress of arterial calcification is regulated by the miR-204/DNMT3a regulatory circuit. (Endocrinology 159: 2905(Endocrinology 159: -2916(Endocrinology 159: , 2018 
diseases. Previously, arterial calcification was considered a passive, degenerative, end-stage process accompanied by calcium-phosphate mineral precipitation in vascular tissue (2) . Although evidence has shown that arterial calcification is an active, complex, and cell-regulated process, which is analogous to mineralization in bone tissues (3) (4) (5) , the specific mechanisms of regulating arterial calcification are still being explored.
miRNAs, a novel class of small noncoding RNAs, are considered important regulators that play a crucial role in many types of physiological and pathological processes (6, 7) . To date, the impacts of miRNAs on vascular smooth muscle cell (VSMC) proliferation, differentiation, calcification, and apoptosis have been investigated in several fields (8, 9) . However, the mechanisms involved in miRNA regulation of the function of VSMCs have not been fully elucidated. In our previous study, we reported that miR-204 regulated mouse VSMC calcification by targeting Runx2 in vitro and in vivo (10) . However, the mechanism involved in the regulation of miR-204 expression during arterial calcification remains unknown.
DNA methylation is one of the most widely studied epigenetic markers. Several lines of evidence suggest that miRNAs are tightly linked to DNA methylation (11) . The hypermethylation of CpG islands in gene promoters or first exon regions, leading to gene silencing, has a profound role in diseases such as cardiovascular diseases and cancers (12, 13) . Nevertheless, whether DNA methylation could mediate the expression of miR-204 and be involved in the process of arterial calcification remains a mystery.
In the current study, we investigated whether miR-204 was regulated by DNA methylation to modulate the differentiation of human aorta VSMCs (HA-VSMCs). The DNA methylation ratio is regulated by DNMT3a, whereas 5-aza-2 0 -deoxycytidine (5-aza) can reduce the level of DNMT3a and thus the demethylation of miR-204 in the osteoblastic differentiation of HA-VSMCs, resulting in an attenuation of the calcification of HAVSMCs in vitro. Interestingly, we also demonstrated that DNMT3a was the target of miR-204 and involved in the differentiation of HA-VSMCs. Therefore, the process of differentiation of HA-VSMCs was regulated via the miR-204/DNMT3a regulatory circuit.
Materials and Methods

Ethics statement
The animal investigation conformed to published guidelines (14) . The human study and human samples conformed to the principles outlined in the Declaration of Helsinki. All the animal and clinical human studies were formally approved by the Ethics Committee of the Second Xiang-Ya Hospital, Central South University. Written informed consent was obtained from all participants in our experiments.
Reagents
We purchased NaH 2 PO 4 (catalog no. 609773), Na 2 HPO 4 (catalog no. 795410), cetylpyridinium chloride (catalog no. 588393) and 5-aza (catalog no. A3656-5MG) from SigmaAldrich (St. Louis, MO). RPMI 1640 and fetal bovine serum (FBS) were purchased from Gibco BRL (Grand Island, NY). Lipofectamine 2000 was purchased from Invitrogen (Carlsbad, CA). Antibodies for Runx2 (catalog no. ab23981; RRID: AB_777785) and transient receptor potential melastatin 3 (TRPM3; catalog no. ab56171; RRID: AB_883241) were purchased from Abcam (Cambridge, United Kingdom). Antibodies for DNMT3a (catalog no. 2160; RRID: AB_2263617) were purchased from Cell Signaling Technology (Boston, MA). Antibodies for b-actin (catalog no. AP53385; RRID: AB_2728738) were purchased from Abgent (San Diego, CA). An miRNA first-strand cDNA synthesis kit (catalog no. QP014), Maxima SYBR Green/ROX qPCR Master Mix (catalog no. AMPR-0600), and all the primers used in this study were purchased from Genecopoeia (Guangzhou, China). Horseradish peroxidase (HRP)-conjugated goat-anti-rabbit secondary antibody, HRP-conjugated goat-anti-mouse secondary antibody, and the enhanced chemiluminescence detection kit were purchased from Santa Cruz Biotechnology (Santa Cruz, TX). MiR-204 mimics, miR-204 inhibitors, and their control oligonucleotides, DNMT3a siRNA oligonucleotides, and the control siRNA oligonucleotides were purchased from Ribobio (Guangzhou, China).
Cell culture and transfection
HA-VSMCs were purchased from the American Type Culture Collection. HA-VSMCs were identified by positive staining of the a-smooth muscle actin. HA-VSMCs were cultured in RPMI 1640 supplemented with 10% FBS. The same batch of HA-VSMCs at different passages (passages 3 to 8) was used in all experiments. To induce calcification, 80% confluent HA-VSMCs were cultured in RPMI 1640 supplemented with 3.3 mM inorganic phosphorus (1:2 NaH 2 PO 4 toNa 2 HPO 4 ; pH 7.0). The transformation to calcified cells was confirmed by the appearance of multilayer nodules detected by Alizarin Red S staining. For the transient transfection of miR-204 mimics, miR-204 inhibitors, or DNMT3a siRNA oligonucleotides, a combination of oligonucleotides (50 nM), and Lipofectamine 2000 were mixed following the manufacturer's instructions. After 6 hours of coculture, the cells were placed in RPMI 1640 supplemented with 10% FBS and cultured for an additional 12 to 24 hours.
Patients and artery tissue samples
A total of 10 pairs of renal artery segments from patients with uremia and healthy donors were obtained from the Department of Urological Organ Transplantation, the Second Xiang-Ya Hospital of Central South University. These were patients with ESRD who require a kidney transplant to maintain a normal life, and the donors were those willing to donate their kidney to patients with ESRD. The mean 6 SD age of the five male and five female patients with uremia was 40.6 6 9.3 years. The mean 6 SD age of the six male and four female healthy donors was 37.9 6 5.5 years. All provided written informed consent to participate in this study. The artery tissues were collected in the process of the kidney transplant surgery.
Some of the samples were fixed with 4% paraformaldehyde for immunohistochemistry and stored at room temperature; other samples were frozen for Western blot and stored in liquid nitrogen.
Gene expression determined using quantitative RT-PCR
Total RNA was extracted from cultured HA-VSMCs, and mice or human artery tissues using Trizol reagent (Invitrogen). For mice and human artery tissues, the tissue was first cut into small fragments with tissue scissors and then the Trizol reagent was added (15) . For mRNA detection, cDNA was synthesized from 1 mg of total RNA using an All-in-One™ first-strand cDNA synthesis kit (catalog no. AORT-0060; Genecopoeia). Then, a 25-mL reverse-transcription reaction was carried out for 10 minutes at 65°C, followed by a second step of 60 minutes at 37°C, 5 minutes at 85°C, and a final hold at 4°C. Quantitative PCR (qPCR) analysis was performed with All-in-One™ qPCR Mix (catalog no. QP003; Genecopoeia) in a LightCycler ® 96 System (Roche, Indianapolis, IN). For qPCR analysis, 20-mL reactions were incubated in a 96-well optical plate at 95°C for 10 minutes, followed by 40 cycles of 95°C for 10 seconds, 62°C for 20 seconds, and 72°C for 15 seconds. Data were normalized to GAPDH values. The following PCR primers used in this study were purchased from Genecopoeia: DNMT1 (catalog no. HQP054460), DNMT3a (catalog no. HQP004411), DNMT3b (catalog no. HQP004414), TRPM3 (catalog no. HQP019488), and GAPDH (catalog no. HQP006940). For miR-204 analysis, the All-in-One™-miRNA quantitative RT-PCR (qRT-PCR) detection system was used (catalog no. AOMD-Q060; Genecopoeia) as described by the manufacturer's protocol and using U6 small nuclear RNA as the reference. Briefly, a 25-mL reversetranscription reaction was carried out for 60 minutes at 37°C, 5 minutes at 85°C, and a hold at 4°C. qPCR was performed for 10 minutes at 95°C, followed by 40 cycles of 10 seconds at 95°C, 20 seconds at 65°C, and 10 seconds at 72°C. The primers for human miR-204 (catalog no. HmiRQP0306), mouse miR-204 (catalog no. MmiRQP0306), and U6 small nuclear RNA (catalog nos. HmiRQP9001 and MmiRQP9002) were all purchased from Genecopoeia. The relative standard curve method (i.e., 2
2DDCT
) was used to determine the relative mRNA and miRNA expression. Results were expressed as fold change relative to the relevant control. The qPCRs were run in triplicate and results are presented as the mean 6 SD of samples.
Measurement of alkaline phosphatase activity, osteocalcin, and mineralized matrix formation
The confluent HA-VSMCs were washed with PBS twice, and then the cell layers were scraped into a solution. The lysates were homogenized and assayed for alkaline phosphatase (ALP) activity by the spectrophotometric measurement of p-nitrophenol release at 37°C (catalog no. A059-2; Jiancheng, Nanjing, China). ALP activity was normalized to total cellular protein by the Bradford protein assay. Osteocalcin (OC) was measured using the Osteocalcin Assay Kit (catalog no. H152; Jiancheng) according to the manufacturer's instructions. Protein expression was normalized to the total protein of the cell layers by the Bradford protein assay.
Alizarin Red S staining was done as previously described (16) . Briefly, cells cultured with 3.3 mM inorganic phosphate (Pi) for 18 days were fixed in 4% paraformaldehyde for 30 minutes at room temperature and then stained with 2% (pH 8.3) Alizarin Red S for 30 to 60 seconds at 37°C. Next, cells were washed with PBS three times to eliminate nonspecific staining. The stained matrix was assessed and photographed using a digital microscope. For the quantification of calcium levels, cells were washed with PBS and decalcified with 0.6 N HCl for 24 hours; calcium content was determined by measuring the concentrations of calcium in the HCl supernatant by atomic absorption spectroscopy. After decalcification, the cells were washed three times with PBS and the cells were solubilized with 0.1 N NaOH/0.1% SDS. The protein content was measured with a bicinchoninic acid protein assay. The calcium content of the cell layer was normalized to the protein content.
Western blot analysis
Protein expression analysis was detected by Western blot analysis, as previously described (17, 18) . Briefly, protein was extracted from HA-VSMCs, and mice or human artery tissues by radioimmunoprecipitation assay (RIPA; Solarbio Life Sciences, Beijing, China) lysis buffer (RIPA to phenylmethylsulfonyl fluoride ratio, 99:1). To extract protein from artery tissues, the artery tissues were removed from the liquid nitrogen and ground, adding liquid nitrogen as necessary. Then, the RIPA lysis buffer was added according to the weight of the tissues. The protein was quantified by using the BCA Protein kit (Beyotime Biotechnology, Shanghai, China). Protein extracts were separated by SDS-PAGE and transferred to polyvinylidene fluoride membranes (Millipore, Billerica, MA). Blots were blocked with 5% nonfat milk in Tris-buffered saline for 1 hour at room temperature. The membranes were incubated with primary antibodies, including anti-Runx2 (1:1000; catalog no. ab23981; Abcam), anti-DNMT3a (1:500; catalog no. 2160; Cell Signaling Technology), anti-TRPM3 (1:1000; catalog no. ab56171; Abcam), and anti-b-actin (1:3000; catalog no. AP53385; Abgent) at 4°C overnight, followed by incubation with the HRP-conjugated goat-anti-rabbit (1:5000; catalog no. sc-2004; Santa Cruz Biotechnology; RRID: AB_631746) or HRP-conjugated goatanti-mouse (1:5000; sc-2005; Santa Cruz Biotechnology; RRID: AB_631736) secondary antibodies at 37°C for 1 hour. The immunoreactive bands were visualized using the ECL Plus Western blot detection kit (Amersham Biosciences UK) and densitometric quantification of band intensity from three independent experiments was carried out with the Image-Pro Plus 6.0 software. The relative expression level of target protein was normalized to the intensity of the b-actin band.
Methylation analysis using bisulphite genomic sequencing PCR
Bisulphite sequencing PCR (BSP) was conducted as described previously (19) . The bisulphite-treated human miR-204 containing 42 CpG sites and mouse miR-204 containing 37 CpG sites was amplified with the primers listed in Supplemental Table 1 . The amplified PCR products were purified and subcloned into the pGM T-Easy vector (Promega, Madison, WI). In total, three clones of experimental samples were sequenced. The percentage of methylated CpG dinucleotides was calculated to evaluate the methylation level of miR-204.
Animals
Twenty 6-week-old female C57/BL/6 mice were randomly divided into two groups: a sham operation group (SOR) and a 5/6 nephrectomy with a high-phosphate diet (5/6 NTP) group. All animals were conventionally housed in standard cages and kept on a 12-hour light:12-hour dark cycle with food and water freely available. The 5/6 NTP mouse model was set up as follows (20) : the mice were anesthetized with an intraperitoneal injection of pentobarbital sodium (50 mg/kg). The absence of the pedal withdrawal reflex was checked frequently to ensure the adequacy of anesthesia, with plans to use more if the mice exhibited any signs of pain during the operation. Heart rate and respiration rate were also monitored by a small-animal monitoring instrument (MouseOx; Starr Life Sciences, Oakmont, PA) during the procedures. Then, a 1.5-to 2.0-cm incision was made parallel to the spine to expose the kidney. The adrenal gland was carefully removed to avoid damage and then the upper pole was resected in one stroke using sharp scissors. This was covered immediately with a piece of gel foam (Spongostan; Johnson & Johnson, New Brunswick, NJ) and mild pressure was exerted with sterile gauze. These steps were repeated with the lower pole of the kidney. The remnant kidney with the adherent gel foam pads was replaced inside the abdomen. The skeletal muscle incision and skin were closed. Two weeks later, the right kidney was then removed completely. SOR mice underwent the same surgery over the same period as the 5/6 NT group, but only the renal capsule was stripped after exposure of the kidney, and then the abdomen was closed. To accelerate the process of aortic calcification, 5/6 NT animals received a high-phosphate diet (0.9% Pi) after completing renal ablation for the duration of the study. Twelve weeks after 5/6 NTP, the uremia model was set up successfully, which was confirmed by a dramatic increase in the level of urea, creatinine, and urine protein in 24 hours compared with the group of SOR mice. The mice were euthanized with an intraperitoneal injection of pentobarbital sodium (150 mg/kg), which was confirmed by the absence of a heartbeat, and then the thoracic aortas were dissected out of the mice.
qRT-PCR was used to measure the expression of miR-204 levels and Western blot analysis and immunohistochemistry staining were used to test for expression of the Runx2 and DNMT3a proteins in aortic tissues. Alizarin Red S staining was used to detect arterial calcification. Some of the artery samples were used for BSP to assess the methylation of miR-204 in aortic tissues. Total protein was quantified using the Bradford protein assay. The calcium content was normalized to the protein content and expressed as micrograms of calcium per milligrams of protein.
Biochemical analysis
Blood was collected from the heart into chilled dry tubes and spun in a refrigerated centrifuge; serum was stored at 280°C. Metabolic cages with an inner diameter of 127 mm, specially designed for mice, were used to collect urine; food and water containers were placed outside the cages to avoid urine contamination. To decrease stress related to the new environment, mice were housed for at least 24 hours before starting the collection. Serum and urine levels of markers were measured with commercially available kits (Jiancheng). The markers to be detected included blood urea nitrogen (catalog no. C013-1), creatinine (catalog no. C011-1), and urinary protein (catalog no. C035-2).
Immunohistochemistry
Artery sections were from mice or human subjects. The calcified arteries were analyzed by Alizarin Red S and immunohistochemistry staining. Arterial samples were fixed and processed by the paraffin-embedded method. Arterial tissue sections were deparaffinized in xylene and rehydrated in a graded ethanol series. To clear endogenous peroxidase, sections were incubated with 3% hydrogen peroxide, followed by antigen retrieval with trypsin. After blocking with 5% BSA, slides were probed overnight at 4°C with polyclonal antibodies against DNMT3a (1:100; Bioss, Beijing, China). The primary antibody was detected by a biotinylated secondary antibody followed by the avidin-biotin peroxidase complex and 3,3 0 -diaminobenzidine chromogen (catalog no. GK500710; Gene Tech, Shanghai). The immunopositive results were measured using a Nikon Eclipse microscope with a Nikon DSR1 camera, and analyzed by Nikon NIS-Elements AR software (Nikon Instruments Korea, Seoul, Korea).
Plasmid constructs
To determine the function of miR-204, a segment of the 3 0 untranslated region (UTR) of human DNMT3a with the predicted binding sites of miR-204 was cloned into XbaI-FseI restriction sites of the pGL3 luciferase reporter vector (Promega). The QuikChange site-directed mutagenesis kit (Stratagene) was used to construct a mutant 3 0 UTR of DNMT3a. The primers are listed in Supplemental Table 2 .
Luciferase reporter assay
HA-VSMCs were cotransfected with a luciferase reporter carrying wild-type DNMT3a 3 0 UTR, mutant DNMT3a 3 0 UTR, and miR-204 mimics or scramble oligonucleotides. Then, 48 hours after transfection, luciferase activities were quantified with the luciferase assay system (Promega). The nucleotide sequences of primers for the construction and mutation of 3 0 UTR DNMT3a mRNA were purchased from Ribobio.
Statistical analysis
The data are presented as mean 6 SD and were analyzed using Statistical Product and Service Solutions software (SPSS, version 19.0; IBM, Armonk, NY). The normality of data distribution was assessed, and the normally distributed data were analyzed using Student t test between two groups. Comparisons of multiple groups were made using one-way ANOVA and the Tukey post hoc test was used after ANOVA. P , 0.05 was considered statistically significant. All experiments were repeated at least three times, and representative experiment results are shown in the figures.
Results
Decreased expression of miR-204 in calcified artery tissues
Renal arterial calcification was confirmed by Alizarin Red S staining ( Fig. 1A; Supplemental Fig. 1 ). The expression of miR-204 was ;12 times lower in calcified renal arteries compared with normal arteries, using quantitative RT-PCR (qRT-PCR) (Fig. 1B) . These results suggested that miR-204 might be involved in regulating arterial calcification.
High phosphate concentration induced osteoblastic differentiation of HA-VSMCs
We observed that high phosphate concentration (i.e., 3.3 mM) can induce the osteoblastic differentiation of HA-VSMCs in a time-dependent manner, which was demonstrated by the significant increase in ALP activity, OC secretion, and Runx2 expression (Fig. 1C-1E ). In addition, bone matrix mineral deposition revealed by Alizarin Red S staining was also increased greatly in high phosphate concentration-induced HA-VSMCs for 18 days (Fig. 1F) . However, the expression of miR-204 detected by qRT-PCR was significantly downregulated in the process of osteoblastic differentiation of HAVSMCs induced by high phosphate concentration (Fig. 1G) . Furthermore, in the 5/6 NTP mice, arterial calcification was confirmed by Alizarin Red S staining (Fig. 1H) . The expression of miR-204 was significantly decreased in calcified mouse arteries from the 5/6 NTP group (Fig. 1I) , whereas the levels of the osteoblastic differentiation markers ALP and Runx2 were increased ( Fig. 1J and 1K ). the miR-204 mimics induced miR-204 levels by .70-fold ( Fig. 2A) . In addition, the overexpression of miR-204 significantly decreased ALP, OC, and Runx2 protein levels, whereas inhibiting the expression of miR-204 produced the opposite results (Fig. 2B-2D) . Transfection of miR-204 mimics elicited decreasing Runx2 expressions, whereas inhibition of miR-204 increased the expression of Runx2 in the presence or absence of 3.3 mM Pi (Supplemental Fig. 2) . Furthermore, these data indicate that miR-204 plays a negative role in the differentiation of HA-VSMCs. The role of miR-204 in the process of arterial calcification in mice had already been validated in our previous study (10) . 
Epigenetic mechanism of miR-204 downregulation in vitro and in vivo
Bioinformatics analysis showed that exon 1 of miR-204 had a typical CpG island (Fig. 2E ) in humans and mice, and BSP showed that the methylation rate of CpG islands of miR-204 in control-group cells was about 24.2%. In high phosphate concentration-induced HAVSMCs with the downregulated expression of miR-204, however, the CpG islands were hypermethylated and the methylation rate reached as high as 61.9% (Fig. 2F) . In accordance with these results, a similar phenomenon was observed in calcified arteries from 5/6 NTP mice and patients with uremia. The BSP assay showed the hypermethylation of miR-204 in calcified mouse arterial tissues isolated from 5/6 NTP mice, with a CpG site methylation rate of 59.89% compared with the SOR group, which had a methylation rate of 19.45% (Fig. 2G) . The methylation rate of miR-204 in the calcified renal arteries from patients with uremia was much higher than that in normal subjects, according to BSP analysis (Fig. 2H ). However, the methylation level of miR-204 was significantly decreased in HA-VSMCs treated with 5-aza, which is a DNA methyltransferase (DNMT) inhibitor (Fig. 2F) . In addition, qRT-PCR revealed that the expression of miR-204 was restored in HA-VSMCs with 5-aza treatment (Fig. 2I) . Taken together, the downregulation of miR-204 in calcified HA-VSMCs was associated with DNA methylation.
TRPM3, a member of the TRPM family, played an important role in regulating the functions of VSMCs (21) . Previous studies had reported that the CpG islands of miR-204 formed a bidirectional promoter that drives the expression of both miR-204 and TRPM3. Thus, the methylation of CpG islands was also associated with the transcriptional silencing of TRPM3 (22) . In the current study, we also found that TRPM3 mRNA was significantly inhibited in calcified HA-VSMCs, and TRPM3 protein levels were significantly decreased in calcified HA-VSMCs compared with the control. However, 5-aza treatment rapidly restored its expression (Supplemental Fig. 3A and 3B ). These data suggest that the downregulation of miR-204 expression in calcified HA-VSMCs was strongly associated with the hypermethylation of neighboring CpG islands, which notably harbor bidirectional promoter activity and also regulate the expression of TRPM3.
DNMT3a mediates DNA methylation of miR-204
DNA methylation occurs at CpG dinucleotides and is regulated by DNMTs, including DNMT1, DNMT3a, and DNMT3b (23) . In an in vitro experiment, an obvious increase in the expression of DNMT3a mRNA was observed by qRT-PCR in calcified HA-VSMCs (Fig. 3A) . However, neither DNMT1 nor DNMT3b expression was significantly different between calcified HA-VSMCs and the control (Supplemental Fig. 4 ). In addition, Western blot analysis showed that the expression of DNMT3a protein was in agreement with the expression of mRNA (Fig. 3B) . However, the treatment of HA-VSMCs with 5-aza remarkably decreased the expression of DNMT3a at the mRNA and protein levels (Fig. 3A and 3B) . In mice, the expression of DNMT3a mRNA was also increased in calcified arteries (Fig. 3C) , and Western blot analysis and immunohistochemistry staining showed an obvious increase in DNMT3a expression in calcified artery tissues compared with normal tissues (Fig. 3D and 3E) . Moreover, the expression of DNMT3a was also increased in the renal arteries of patients with uremia, which was demonstrated by Western blot analysis and immunohistochemistry staining ( Fig. 3F and 3G ). Thus, these data suggest that the mechanism by which miR-204 regulates the osteoblastic differentiation of HAVSMCs might be modulated by DNMT3a.
DNMT3a is the target of miR-204 and involved in regulating the differentiation of HA-VSMCs
To explore the downstream mechanism of miR-204 regulating the differentiation of HA-VSMCs, we began to seek the target genes of miR-204. Interestingly, bioinformatics analysis showed that miR-204 was predicted to have a potential miRNA binding site in the 3 0 UTR of DNMT3a (Fig. 4A) . In cultured HA-VSMCs, the overexpression of miR-204 by transfecting miR-204 mimics to HA-VSMCs significantly reduced DNMT3a protein expression, whereas miR-204 inhibitors moderately increased DNMT3a protein expression (Fig. 4B) . In addition, a luciferase reporter construct containing the wild-type or mutant 3 0 -UTR coding sequences for DNMT3a was generated and introduced with miR-204 mimics into HA-VSMCs. The overexpression of miR-204 significantly decreased the relative luciferase activity of the wild-type 3 0 UTR of DNMT3a reporter plasmids, but after the miR-204 seed sequence in the DNMT3a mRNA 3 0 UTR was mutated, the inhibitory effect of miR-204 on the relative luciferase activity was abrogated (Fig. 4C) . Scramble miRNA mimics, however, did not affect the wild-type or mutant constructs, confirming the specificity of the action. These data suggest that DNMT3a was the direct target of miR-204.
To further confirm our speculation that DNMT3a played a central role in regulating the expression of miR-204 and modulated the osteoblastic differentiation of HA-VSMCs, we transfected DNMT3a siRNA into HAVSMCs to knock down the expression of DNMT3a (Fig. 4D) . Of the three independent small interfering DNMT3a (siDNMT3a) sequences we designed, Western blot analysis showed two that could knock down the expression of DNMT3a successfully, but only the third siDNMT3a knocked down the expression of DNMT3a significantly (Supplemental Fig. 5 ). Therefore, we chose the third siDNMT3a for further study in our research. The results showed that the effect of high phosphate concentration, in terms of the lower expression of miR-204, was abolished (Fig. 4E) . Furthermore, the effects of high phosphate concentration on the expression of osteoblastic markers, such as ALP activity, OC secretion, and Runx2 expression, were also diminished when DNMT3a was knocked down (Fig. 4F-4H) . Moreover, the methylation rate of CpG sites of miR-204 DNA was significantly lower in HA-VSMCs when DNMT3a was knocked down (Supplemental Fig. 6 ). That is, knocking down the expression of DNMT3a completely blocked the effects of high phosphate concentration on the osteoblastic differentiation of HA-VSMCs and restored the expression of miR-204. Taken together, miR-204 regulation of the osteoblastic differentiation of HA-VSMCs was dependent on the expression of DNMT3a and the process of osteoblastic differentiation of HAVSMCs was regulated via the miR-204/DNMT3a regulatory circuit.
Discussion
In the current study, we have shown that miR-204 was decreased in HA-VSMCs with high phosphate concentration treatment and acted as a negative regulator during the process of osteoblastic differentiation of HA-VSMCs. Most interestingly, our results demonstrated that the methylation level of miR-204 was regulated by DNMT3a, while DNMT3a was also the target of miR-204 and was involved in the process of HA-VSMC differentiation. Therefore, the differentiation of HA-VSMCs was regulated via the miR-204/DNMT3a regulatory circuit (Fig. 4I) .
Arterial calcification, a well-regulated process that involves the transdifferentiation of VSMCs into osteoblastlike cells, is crucial to a variety of cardiovascular pathologies. (26) showed that the miR-130/301-peroxisome proliferatoractivated receptor g regulatory axis controls proliferation by increasing STAT3 expression and activity and repressing subordinate miR-204 expression in pulmonary artery smooth muscle cells. These studies showed that miR-204 plays an important role in the function of VSMCs.
In the current study, we found that miR-204 was downregulated in HA-VSMCs induced by a high concentration of phosphate and involved in regulating the process of osteogenic differentiation of HA-VSMCs. These results differ from those of the study of Panizo et al. (27) , in which they showed that high phosphate concentration had no significant effect on the expression of miR-204 in rats with chronic kidney disease (CKD) compared with the control. However, they also emphasized that they could not discount the possibility that miR-204 might be a mediator of the calcification process. We propose that the different animal species might explain the different results.
Recently, epigenetic modification has become an important and crucial method for the regulation of gene expression; these modification mechanisms include DNA methylation, histone modifications, acetylation, and miRNAs (28) . However, there have only been a few studies of the combined effect of miRNAs and DNA methylation on the function of VSMCs. One of the studies showed that miR-1298 was regulated by DNA methylation and affected the proliferation and migration of VSMCs by targeting connexin 43 (29) . Two other studies showed that miR-125 could reduce the methylation level of p53 by targeting DNMT3b, thus promoting https://academic.oup.com/endothe proliferation of VSMCs, and that DNMT3a was responsible for the hypermethylation of miR-143 in Hcyinduced VSMC proliferation (30, 31) . It is unfortunate, however, that there are no reports about the relationship between miRNAs and methylation in the process of VSMC differentiation. In the current study, bioinformatics analysis showed that miR-204 was transcribed in the same orientation as the TRPM3 transcript and that both share the same promoter (32) . At the same time, the upstream DNA features of the miR-204 had a typical CpG island, so we hypothesized that miR-204 might be regulated by methylation. BSP results showed that the CpG sites of miR-204 upstream DNA were hypermethylated in calcified HA-VSMCs and calcified artery tissues. Moreover, the CpG sites of miR-204 DNA formed a bidirectional promoter, which drives the expression of both miR-204 and TRPM3. Therefore, the TRPM3 mRNA and protein levels were significantly decreased in calcified HA-VSMCs compared with the control. Interestingly, treating HA-VSMCs with 5-aza, a DNMT inhibitor, greatly decreased the methylation level of miR-204 and rapidly restored miR-204 and TRPM3 expression. These data suggest that the downregulation of miR-204 expression in high phosphate concentrationinduced HA-VSMC calcification is strongly associated with hypermethylation of the neighboring CpG island. In addition, BSP also showed that the methylation rate of miR-204 in 5/6 NTP mouse arteries and renal arteries of patients with uremia was higher than that of SOR mice and healthy donors, respectively. However, whether the expression of miR-204 was mediated by methylation in 5/ 6 NTP mice and if 5-aza has a similar role in mice to HAVSMCs require further investigation. DNA methylation is mediated by several DNMTs, including DNMT1, DNMT3a, and DNMT3b (33) , and it has been found that these DNMTs play a role in different cell functions. For example, Zhang et al. (31) reported that DNMT3a was a direct target of miR-143 and DNMT3a was responsible for the hypermethylation of miR-143 in homocysteine-induced VSMC proliferation. Azechi et al. (34) also demonstrated that the downregulation of DNMT1 expression facilitated the inorganic phosphorus-induced arterial calcification via the upregulation of ALP expression, along with a reduction in the DNA methylation level of the ALP promoter region. Another study, Montes de Oca et al. (35) showed that high phosphate concentration-induced calcification was related to SM22a promoter methylation in VSMCs, which was modulated by DNMTs. They found that DNMT activity was increased in VSMCs induced by high phosphate concentration, but the authors did not further clarify which of the DNMTs had the specific effect of methylating SM22a (35) . Our research showed that in calcified HA-VSMCs showing the hypermethylation of miR-204, the expression of DNMT3a, but not DNMT1 or DNMT3b, was significantly increased at the mRNA and protein levels. Also, an obvious increase in the expression of DNMT3a was observed in arterial tissues derived from 5/6 NTP mice and patients with uremia. Previous studies demonstrated that DNMT1 contributed to the maintenance of DNA methylation patterns, whereas DNMT3a and DNMT3b promoted methylation at previously unmethylated CpG sites (31) . This might explain why only DNMT3a was regulated during the process of HA-VSMC calcification. However, when HA-VSMCs were treated with 5-aza, the expression of DNMT3a was significantly decreased and thus the expression of miR-204 was restored. Hence, the increased expression of DNMT3a resulting in the hypermethylation of miR-204 may be the cause of the downregulation of miR-204 in the process of HA-VSMC calcification. Nevertheless, the role of DNMT3a in vivo needs further study.
MiRNAs usually regulate gene expression through binding to the 3 0 -UTR sites of their target genes (36, 37 ). In the current study, there were three key clues to support the hypothesis that DNMT3a is a crucial target of miR-204 in HA-VSMCs. First, the overexpression or inhibition of the expression of miR-204 could significantly decrease or increase the expression of DNMT3a, respectively. Second, the overexpression of miR-204 significantly suppressed the luciferase activity of the wild-type 3 0 UTR of the DNMT3a reporter gene but not that of the mutant DNMT3a. Third, ALP activity, OC secretion, and Runx2 expression were completely blocked when knocked down by using DNMT3a siRNA in HA-VSMCs. Collectively, these results confirm the view that miR-204 inhibits HA-VSMC calcification by downregulating DNMT3a, and that DNMT3a is involved in regulating the differentiation of HA-VSMCs. On the one hand, the increased expression of DNMT3a could promote the methylation of miR-204 and then downregulate the expression of miR-204; on the other hand, DNMT3a was the target of miR-204 and the expression of DNMT3a could be regulated by miR-204. When miR-204 was downregulated, the DNMT3a expression was significantly increased, which, in turn, reduced the expression of miR-204 via modulating the methylation of miR-204. Finally, this resulted in an acceleration of the calcification of HA-VSMCs.
Most importantly, numerous studies have demonstrated that arterial calcification is a significant contributor to the cardiovascular mortality observed in patients with ESRD (38, 39) . Though Pi plays a critical role in bone mineralization and various cellular functions in mice and humans, high phosphate concentration was one of the major characteristics in mice and patients with
